Glazer, A., M. Tassavor, D. Portela, and T. Soleymani. “The Integrated 31-Gene Expression Profile Test (i31-GEP) for Cutaneous Melanoma Outperforms the CP-GEP at Identifying Patients Who Can Forego Sentinel Lymph Node Biopsy When Applying NCCN Guidelines”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, pp. 474-81, doi:10.25251/skin.6.6.4.